Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation (Q42863719)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 October 2010

Language	Label	Description	Also known as
English	Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation	scientific article published on 8 October 2010

Statements

scholarly article

1 reference

Europe PubMed Central

8 November 2017

Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation (English)

1 reference

Europe PubMed Central

8 November 2017

0 references

1 reference

based on heuristic

inferred from title

Jeffrey A. Hubbell

object named as

Jeffrey A Hubbell

4

0 references

author name string

Sachiko Hirosue

1

1 reference

Europe PubMed Central

8 November 2017

Iraklis C Kourtis

2

1 reference

Europe PubMed Central

8 November 2017

André J van der Vlies

3

1 reference

Europe PubMed Central

8 November 2017

Melody A Swartz

5

1 reference

Europe PubMed Central

8 November 2017

language of work or name

0 references

publication date

8 October 2010

1 reference

Europe PubMed Central

8 November 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

8 November 2017

28

1 reference

Europe PubMed Central

8 November 2017

50

1 reference

Europe PubMed Central

8 November 2017

7897-7906

1 reference

Europe PubMed Central

8 November 2017

Effector and memory CTL differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Virosomal adjuvanted antigen delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Exploiting lymphatic transport and complement activation in nanoparticle vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Activation of lysosomal function during dendritic cell maturation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Targeting proteins to distinct subcellular compartments reveals unique requirements for MHC class I and II presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Characterization of poly(D,L-lactic-co-glycolic acid) based nanoparticulate system for enhanced delivery of antigens to dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Short peptide sequences containing MHC class I and/or class II epitopes linked to nano-beads induce strong immunity and inhibition of growth of antigen-specific tumour challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Concomitant delivery of a CTL-restricted peptide antigen and CpG ODN by PLGA microparticles induces cellular immune response

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Acid-degradable particles for protein-based vaccines: enhanced survival rate for tumor-challenged mice using ovalbumin model

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Selective transport of internalized antigens to the cytosol for MHC class I presentation in dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

PEG-SS-PPS: reduction-sensitive disulfide block copolymer vesicles for intracellular drug delivery.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Reduction-sensitive polymers and bioconjugates for biomedical applications

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Formulation of highly soluble poly(ethylene glycol)-peptide DNA condensates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Antibody-maytansinoid conjugates are activated in targeted cancer cells by lysosomal degradation and linker-dependent intracellular processing.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Tumor delivery and in vivo processing of disulfide-linked and thioether-linked antibody-maytansinoid conjugates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Synthesis of pyridyl disulfide-functionalized nanoparticles for conjugating thiol-containing small molecules, peptides, and proteins

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Oxidation-sensitive polymeric nanoparticles.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Dynasore, a cell-permeable inhibitor of dynamin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Filipin-dependent inhibition of cholera toxin: evidence for toxin internalization and activation through caveolae-like domains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Bafilomycins: a class of inhibitors of membrane ATPases from microorganisms, animal cells, and plant cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

A role for phosphoinositide 3-kinase in the completion of macropinocytosis and phagocytosis by macrophages

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Distinct endocytotic pathways in epidermal growth factor-stimulated human carcinoma A431 cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Constitutive macropinocytosis allows TAP-dependent major histocompatibility complex class I presentation of exogenous soluble antigen by bone marrow-derived dendritic cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Post-proteasomal antigen processing for major histocompatibility complex class I presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

PAProC: a prediction algorithm for proteasomal cleavages available on the WWW.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

An IFN-gamma-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

MHC class II molecules on the move for successful antigen presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

NOX2 Controls Phagosomal pH to Regulate Antigen Processing during Crosspresentation by Dendritic Cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

In vivo cross-priming of MHC class I-restricted antigens requires the TAP transporter.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Oxidized redox state of glutathione in the endoplasmic reticulum

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Generation of major histocompatibility complex class I antigens: functional interplay between proteasomes and TPPII.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Dendritic cells process antigens encapsulated in a biodegradable polymer, poly(D,L-lactide-co-glycolide), via an alternate class I MHC processing pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

ISCOMATRIX adjuvant induces efficient cross-presentation of tumor antigen by dendritic cells via rapid cytosolic antigen delivery and processing via tripeptidyl peptidase II.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Early phagosomes in dendritic cells form a cellular compartment sufficient for cross presentation of exogenous antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

ER-phagosome fusion defines an MHC class I cross-presentation compartment in dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Antigen loading of MHC class I molecules in the endocytic tract

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT)

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

IRAP identifies an endosomal compartment required for MHC class I cross-presentation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

The detailed distribution of HLA-A, B, C antigens in normal human organs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2010.09.077

7 January 2021

Identifiers

10.1016/J.VACCINE.2010.09.077

1 reference

Europe PubMed Central

8 November 2017

1 reference

Europe PubMed Central

8 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42863719&oldid=1972821944"